Nucleoporin 43 (Nup43) is a protein that in humans is encoded by the NUP43gene.[5][6]
Bidirectional transport of macromolecules between the cytoplasm and nucleus occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope. NPCs are composed of subcomplexes, and NUP43 is part of one such subcomplex, Nup107-160 (Loiodice et al., 2004).[supplied by OMIM][6] Along with other nucleoporins.
High expression of NUP43 in breast cancer is associated with poor overall survival.[9] In chronic myelogenous leukemia (CML), reduction of miRNA-409-5p increases the expression of NUP43 that in turn enhances proliferative potential, cell cycle progression, and imatinib resistance.[10]
^Tian C, Zhou S, Yi C (June 2018). "High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer". Future Oncology. 14 (15). London, England: 1431–1442. doi:10.2217/fon-2017-0690. PMID29402145. S2CID46780926.
^Liu YY, Jiao WY, Li T, Bao YY (October 2019). "MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia". European Review for Medical and Pharmacological Sciences. 23 (19): 8468–8475. doi:10.26355/eurrev_201910_19159. PMID31646577. S2CID204865406.
^Fahira A, Li Z, Liu N, Shi Y (May 2019). "Prediction of causal genes and gene expression analysis of attention-deficit hyperactivity disorder in the different brain region, a comprehensive integrative analysis of ADHD". Behavioural Brain Research. 364: 183–192. doi:10.1016/j.bbr.2019.02.010. PMID30738099. S2CID72334804.